A large-scale drug trafficking organisation linked to Colombian and Peruvian cartels was dismantled in Spain and Colombia in an international law enforcement operation. Europol supported the two-year-long investigation, led by the Spanish Civil Guard (Guardia Civil) in close collaboration with the National Police of Colombia and the US DEA.
EMCDDA Director Alexis Goosdeel is in Washington today where he will meet Ambassador Adam Namm, Executive Secretary of the Inter-American Drug Abuse Control Commission (CICAD). The purpose of the visit is to discuss ongoing EMCDDA–CICAD cooperation and review the topics to be addressed under the joint work programme (2020–2024). Respectively, the two organisations lead the regional drug information systems of Europe and the Americas and, in so doing, make a valuable contribution to evidence-based information on drugs at global level.
Europol supported a pan-European operation targeting the illicit online and offline trafficking of misused and counterfeit medicines. The operation was led by Finnish Customs (Tulli) and the Central office against environmental and public health crime of the French National Gendarmerie (Gendarmerie Nationale, Office central de lutte contre les atteintes à l’environnement et à la santé publique) and involved law enforcement authorities from 11* EU Member States, Bosnia and Herzegovina, Ukraine, US Drug Enforcement Agency (DEA) and the European Anti-Fraud Office (OLAF). The operation took place between 15 and 18 October 2019, the results of which can only be released now for operational reasons.
With the support of Eurojust, EU Member States last year tackled illicit drug trafficking worth over EUR 2.8 billion. Approximately EUR 2 billion in criminal assets were frozen and over a thousand weapons, mobile phones, laptops and cars were seized. A total of 2 686 suspects were arrested or surrendered to other Member States, through action days, coordination meetings and other judicial support provided by Eurojust. These first operational achievements were presented today to European Commissioner for Justice Mr Didier Reynders by Eurojust President Mr Ladislav Hamran.
From 16 December 2019, edible cannabis products are permitted to be sold in Canada. These must comply with new regulations for edible, inhalable and topical products, designed to reduce the risk of accidental consumption or overconsumption. Edible products are not individually approved for sale, but the regulations instruct manufacturers to provide Health Canada with a written notice of the product – including class of product, description and expected date of offering for sale – then wait 60 days before sale, to give the authorities time to raise any concerns. As the new regulations came into force on 17 October 2019, the earliest date for the sale of edible cannabis products was therefore 16 December 2019. Herbal cannabis products and cannabis oils have been on sale in licensed shops in Canada since 17 October 2018.
This annual conference will bring legal practitioners working with the pharmaceutical sector up-to-date on the latest relevant regulatory developments, legislative initiatives and case law.